[et_pb_section fb_built=”1″ _builder_version=”3.22″][et_pb_row _builder_version=”3.25″ background_size=”initial” background_position=”top_left” background_repeat=”repeat”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.6.5″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” hover_enabled=”0″ sticky_enabled=”0″]

After months of interviews with leading Wall Street Journal health reporter Amy Dockser Marcus, PRF is featured in a front page article in a recent issue of the publication. Click here to access the Wall Street Journal article online.

For six months, Marcus followed PRF Medical Director, Dr. Leslie Gordon, and her colleagues through the arduous process of preparing for and launching a clinical trial for children with Progeria. The piece highlights PRF’s efforts to drive Progeria research towards treatment and a cure for this devastating disease. PRF will fund a first-ever drug treatment trial for Progeria in Boston, MA using a drug called FTI. PRF must raise $2 million to fund the trial – thanks to generous donations from our supporters we are raising the money, but need your help to reach that goal.
Click here for Ways to Donate to PRF

Contact us for a copy of the article.

Thank you for supporting PRF and children living with Progeria worldwide.

[/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section]